Literature DB >> 12435891

Psychosocial adaptation to short stature - an indication for growth hormone therapy?

Thorsten Wygold1.   

Abstract

Although growth hormone does not clearly improve final height in non-growth-hormone-deficient children with short stature, it leads to a temporary acceleration of growth velocity. It is an ongoing discussion whether this effect supports psychosocial adaptation to short stature and therefore could be an indication for growth hormone treatment in children with short stature without growth hormone deficiency. We have reviewed recent literature concerning psychosocial consequences of short stature. Together with own data we can demonstrate that short people regularly adapt well to their height and have a good self-esteem. On the other hand, we focus on the problem that most studies on this subject suffer from methodical problems. A growth-related questionnaire that evaluates subjective and objective perceptions of being short in patients and peers is not at hand. As a consequence, psychosocial problems due to short stature have not been exactly classified yet and therefore do not represent an indication for growth hormone therapy. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435891     DOI: 10.1159/000066485

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  2 in total

1.  Understanding the impact of statural height on health-related quality of life in German adolescents: a population-based analysis.

Authors:  Rachel Sommer; Anne Daubmann; Julia Quitmann; Ulrike Ravens-Sieberer; Monika Bullinger
Journal:  Eur J Pediatr       Date:  2014-12-24       Impact factor: 3.183

2.  Assessing the quality of life of health-referred children and adolescents with short stature: development and psychometric testing of the QoLISSY instrument.

Authors:  Monika Bullinger; Julia Quitmann; Mick Power; Michael Herdman; Emmanuelle Mimoun; Kendra DeBusk; Eva Feigerlova; Carolina Lunde; Maria Dellenmark-Blom; Dolores Sanz; Anja Rohenkohl; Andreas Pleil; Hartmut Wollmann; John E Chaplin
Journal:  Health Qual Life Outcomes       Date:  2013-05-07       Impact factor: 3.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.